You are here: Industry Insights > Asthma

News List

TSG12 provides a non-toxic therapeutic treatment for asthma europeanpharmaceuticalreview
April 29, 2019
Researchers have identified a new treatment that could lead to more effective drug therapy for individuals with asthma and other respiratory disorders…
Asthma Myths That Can Hurt You drugs
April 24, 2019
Even though asthma is common in the United States, there are many misconceptions about the respiratory disease, an allergy/immunology expert says.
More than 40 percent of women with asthma may develop COPD europeanpharmaceuticalreview
April 22, 2019
“Previous studies have found an alarming rise in ACOS in women in recent years and that the mortality rate from ACOS was higher in women,” said Prof To…
In Utero Ultrafine Particle Exposure Tied to Asthma in Offspring drugs
March 19, 2019
Exposure to ultrafine particles (UFPs; <0.1 μm) during the second trimester in utero is linked to the subsequent onset of asthma in children, according to a study published online Feb. 20 in the American Journal of Respiratory and Critical Care Medicine.
Regeneron/Sanofi wins US approval for expanded use of skin drug expressbpd
March 14, 2019
The US Food and Drug Administration said it approved expanded use of Regeneron Pharmaceuticals Inc and Sanofi SA’s eczema drug Dupixent to include patients aged between 12 and 17
AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children drugs
February 28, 2019
Egg-allergic children who undergo egg oral immunotherapy (eOIT) and achieve sustained unresponsiveness (SU) eat more egg and have fewer symptoms five years later....
UK performs badly in international comparison of health of young people pharmaceutical-technology
February 21, 2019
An international comparative study found that despite young people in the UK making better choices about their health, particularly in terms of alcohol consumption and smoking....
flutiform pMDI to be available for treatment of children 5+ with asthma firstwordpharma
January 15, 2019
This new paediatric licence provides for a regular asthma maintenance treatment option, with a dose of two puffs (actuations) 50/5 µg twice-daily, in children aged 5 years and over, when a combination of an inhaled corticosteroid (ICS) and a long-acting β
Propeller Health announces My Pharmacy, enabling in-app pharmacy experience for patients with asthma and COPD firstwordpharm
January 10, 2019
Propeller Health, a leading digital therapeutics company, today announced My Pharmacy, connecting Propeller users living with asthma and chronic obstructive pulmonary disease (COPD) directly to pharmacy services in the Propeller mobile app.
Sanofi, Sema4 launch 5-year, real-world digital asthma study fiercebiotech
January 02, 2019
Sanofi and Sema4 have launched a five-year longitudinal study of nearly 1,200 asthma patients, with plans to incorporate digital tools to develop a better understanding of the disease....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page